Gate2Brain semifinalist of EITHealth’s Catapult 2022

EITHealth Catapult 2022eithealth

We’re proud to share that Gate2Brain is semifinalist of EITHealth‘s Catapult 2022.

Thanks to this programme we will pitch our solution to experts and industry leaders for the opportunity to receive funding to catapult our start-up to success.

Catapult showcases the best business concepts from medtech, biotech and digital health to leading experts and investors. Their programme offers intensive training and fierce competition and gives start-ups the support they need to be investment-ready and succeed:  eithealth.eu/programmes/catapult

/by
You might also like
G2B receives funding to accelerate its transfer to the market and society
Gate2Brain among the 20 BioTech Startups to Watch in 2024
talento científicotalento cientificoFounding a company in times of pandemic
‘Tractor’ proteins that carry drugs to the brain as therapy for incurable pediatric cancer
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
desafio singaporeICEXDesafía Singapore
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i GimperaThree University of Barcelona spin-offs receive funding from Women TechEU
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Exploration Science with Dr. Wendy HarsockWithin the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEMmedicines beyond barriersG2BMedicines beyond barriers